Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 281 to 288 of 288

Publication Record

Connections

Localization of transforming growth factor alpha and its receptor in gastric mucosal cells. Implications for a regulatory role in acid secretion and mucosal renewal.
Beauchamp RD, Barnard JA, McCutchen CM, Cherner JA, Coffey RJ
(1989) J Clin Invest 84: 1017-23
MeSH Terms: Adult, Aged, Aged, 80 and over, Animals, Blotting, Northern, Carcinoma, DNA Probes, Dogs, ErbB Receptors, Gastric Acid, Gastric Mucosa, Guinea Pigs, Humans, Middle Aged, RNA, Messenger, Rats, Stomach Neoplasms, Transforming Growth Factors
Show Abstract · Added June 14, 2013
Transforming growth factor alpha (TGF alpha) shares with epidermal growth factor (EGF) structural homology (35%), a common cell-surface membrane receptor (TGF alpha/EGF receptor), and a nearly identical spectrum of biological activity, including inhibition of gastric acid secretion. Herein, we report expression of TGF alpha mRNA in normal gastric mucosa of the adult guinea pig, rat, and dog. TGF alpha mRNA was also detected in matched surgically resected gastric mucosa and adjacent gastric carcinoma from 10 patients, and in gastric mucosa adjacent to a benign ulcer from an additional patient. TGF alpha protein was quantitated by radioimmunoassay and was present in tumor and adjacent mucosa. TGF alpha/EGF receptor mRNA was also detected in gastric mucosa from all species studied. Localization of TGF alpha and TGF alpha/EGF receptor mRNA expression was examined in samples of unfractionated guinea pig gastric mucosa and from chief cell-enriched and parietal cell-enriched fractions. All samples exhibited TGF alpha and TGF alpha/EGF receptor expression. The TGF alpha signal was greatest in the parietal cell fraction (5.8-fold increase), but was also enhanced in the chief cell fraction (1.9-fold increase) relative to the unfractionated gastric mucosa. Like TGF alpha expression, TGF alpha/EGF receptor mRNA expression was most intense in the parietal cell-enriched fraction (7.8-fold increase), but was also increased in the chief cell-enriched fraction (2.7-fold increase) relative to the unfractionated guinea pig gastric mucosa. We conclude that TGF alpha and TGF alpha/EGF receptor genes are expressed in normal adult mammalian gastric mucosa. These findings, when interpreted in light of described actions of TGF alpha and EGF, provide evidence that local production of TGF alpha could play an important role in the regulation of acid secretion and mucosal renewal in the stomach.
2 Communities
2 Members
0 Resources
18 MeSH Terms
Helicobacter pylori-like microorganisms and chronic active gastritis in ferrets.
Gottfried MR, Washington K, Harrell LJ
(1990) Am J Gastroenterol 85: 813-8
MeSH Terms: Animals, Campylobacter, Campylobacter Infections, Carnivora, Chronic Disease, Clinical Enzyme Tests, Disease Models, Animal, Ferrets, Gastric Mucosa, Gastritis, Male, Microbial Sensitivity Tests, Urease
Show Abstract · Added April 12, 2016
To determine the prevalence and histology of Helicobacter pylori (HP) associated gastritis in young ferrets, we examined 36 normal 2- to 4-month old ferrets. Identification of HP-like microorganisms included Warthin Starry stains of tissue sections, rapid urease test on fresh tissue, and culture. HP-like microorganisms were found in the stomachs of 35/36 ferrets. The highest density of microorganisms was seen in the antrum, where HP-like microorganisms were present in the pits and in deep glands. HP-like microorganisms were also seen in the cardia and on the foveolar epithelium of the fundus, but not in fundic glands. Chronic active gastritis was seen in all animals with HP-like microorganisms, but involved only the antrum. The distal antrum was most severely involved. One animal had no evidence of HP-like microorganisms on tissue sections or by rapid urease test. Gastric tissue sections from this animal showed only minimal infiltration of the lamina propria by polymorphonuclear leukocytes and lymphocytes. Gastritis associated with HP-like microorganisms is common in ferrets and is acquired at a young age. It is associated with chronic active antral gastritis similar to that seen in humans, suggesting that ferrets should provide a useful experimental model for HP-associated gastritis and peptic ulcer.
0 Communities
1 Members
0 Resources
13 MeSH Terms
Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
Geer RJ, Richards WO, O'Dorisio TM, Woltering EO, Williams S, Rice D, Abumrad NN
(1990) Ann Surg 212: 678-87
MeSH Terms: Adult, Aged, Blood Glucose, Diarrhea, Double-Blind Method, Dumping Syndrome, Female, Gastric Emptying, Gastrointestinal Hormones, Glucagon, Humans, Insulin, Male, Middle Aged, Octreotide, Placebos, Prospective Studies, Pulse
Show Abstract · Added December 10, 2013
The present study evaluates the acute and chronic use of a long-acting somatostatin analog, octreotide acetate, in the treatment of patients with severe postgastrectomy dumping syndrome. In the acute phase, 10 patients with severe dumping were studied over 2 consecutive days before and for 3 hours after the ingestion of a 'dumping breakfast' in a randomized double-blind fashion. On one day octreotide (100 micrograms) was given subcutaneously 30 minutes before the test meal and on the other day an equal volume of vehicle was injected. An additional group of six postgastrectomy patients without dumping were studied in a similar fashion and these acted as controls. During placebo treatment the test meal resulted in an immediate increase (p less than 0.01) in the pulse rate and in plasma levels of glucose, glucagon, pancreatic polypeptide, neurotensin, and insulin. Similar changes were seen in the control group with respect to placebo; however glucagon and neurotensin (p less than 0.05) did not show the same magnitude of increase as seen with placebo. Treatment with octreotide acetate prevented the development of both vasomotor and gastrointestinal symptoms and completely ablated all of the above responses in plasma peptides. These changes were associated with complete ablation of diarrhea (p less than 0.001). Pretreatment with octreotide acetate completely suppressed the rise in plasma insulin response to the meal and this ablated the late hypoglycemia of dumping. Treatment with octreotide acetate resulted in delayed gastric emptying and transit time (578 +/- 244 minutes) versus 76 +/- 23 minutes with placebo and 125 +/- 36 minutes in controls (p less than 0.05). Chronic daily treatment with octreotide acetate resulted in minimal side effects. These patients demonstrated a stable fasting plasma glucose, normal liver function tests, and an average weight gain of 11% during a 12-month period. In addition most patients were able to resume employment. The long-acting somatostatin analog, octreotide acetate, is highly effective in preventing the development of symptoms of severe dumping syndrome, both vasomotor and gastrointestinal.
0 Communities
1 Members
0 Resources
18 MeSH Terms
Obesity surgery in the United Kingdom: survey of 970 general surgeons.
Owen ER, Cooper MK, Kark AE
(1991) Ann R Coll Surg Engl 73: 36-8
MeSH Terms: Attitude of Health Personnel, Gastric Bypass, Gastroplasty, Humans, Jejunoileal Bypass, Obesity, Morbid, United Kingdom
Show Abstract · Added March 5, 2014
The results of a questionnaire survey on obesity surgery sent to 970 consultant general surgeons working in the United Kingdom National Health Service are presented. The response rate was 37%. There were 38 surgeons actively practising this surgery. The majority were performing a gastric procedure, mostly gastroplasty, but some did gastric bypass or banding. Three were doing the biliopancreatic bypass. Most surgeons were doing less than 10 operations a year. A total of 109 expressed an interest in attending a UK symposium and 59 would participate in a UK Bariatric Register. This practice, though only a small part of UK surgery, is larger than expected.
0 Communities
1 Members
0 Resources
7 MeSH Terms
Peptic ulcer diseases in children.
Acra SA, Nakagawa N, Ghishan FK
(1991) Compr Ther 17: 22-6
MeSH Terms: Anti-Ulcer Agents, Child, Gastric Acid, Humans, Peptic Ulcer
Added October 8, 2015
0 Communities
1 Members
0 Resources
5 MeSH Terms
Increased production of transforming growth factor alpha following acute gastric injury.
Polk WH, Dempsey PJ, Russell WE, Brown PI, Beauchamp RD, Barnard JA, Coffey RJ
(1992) Gastroenterology 102: 1467-74
MeSH Terms: Animals, DNA, Epidermal Growth Factor, Gastric Juice, Gastric Mucosa, Hydrochloric Acid, Male, RNA, Messenger, Rats, Rats, Inbred Strains, Transforming Growth Factor alpha
Show Abstract · Added December 10, 2013
Transforming growth factor alpha (TGF-alpha) production recently has been found in normal mammalian gastric mucosa. Inasmuch as TGF-alpha and epidermal growth factor (EGF) both stimulate epithelial cell migration and proliferation and suppress gastric acid secretion, the authors of the current study proposed that these growth factors may participate in tissue repair after acute gastric mucosal injury. Consequently, TGF-alpha and EGF production were examined after orogastric administration of either acidified taurocholate or 0.6 mol/L HCl to rats. TGF-alpha messenger RNA (mRNA) expression increased in a dose- and time-dependent manner after administration of taurocholate, whereas EGF mRNA expression was not detected. Radioimmunoassay of gastric mucosal scrapings obtained 6 hours after gastric injury induced by 0.6 mol/L HCl showed a 2.1-fold increase in immunoreactive TGF-alpha but no increase in immunoreactive EGF. In addition, there was a 68-fold increase in immunoreactive TGF-alpha in gastric juice within 30 minutes of gastric instillation of HCl and, again, no increase in immunoreactive EGF. There is a rapid appearance of TGF-alpha in the gastric juice within 30 minutes of injury, which is followed by increased expression of TGF-alpha mRNA and protein in the gastric mucosa. These studies suggest that locally produced TGF-alpha may participate in gastric mucosal repair following acute gastric injury to rats.
2 Communities
3 Members
0 Resources
11 MeSH Terms
Roles for transforming growth factor-alpha in gastric physiology and pathophysiology.
Coffey RJ, Romano M, Polk WH, Dempsey PJ
(1992) Yale J Biol Med 65: 693-704; discussion 621-3
MeSH Terms: Amino Acid Sequence, Animals, Gastric Mucosa, Humans, Molecular Sequence Data, Stomach, Stomach Diseases, Transforming Growth Factor alpha
Show Abstract · Added March 27, 2014
Transforming growth factor alpha (TGF alpha) is a 5.6 kd single-chain polypeptide that acts through binding to the epidermal growth factor receptor (EGFR). TGF alpha is produced in a wide range of normal as well as embryonic and neoplastic cells and tissues. TGF alpha and EGFR, but not EGF, are expressed in normal gastric mucosa. We have identified the following biological roles for TGF alpha in the stomach, using a variety of primate and rodent models: inhibition of acid secretion; stimulation of mucous cell growth; protection against ethanol- and aspirin-induced injury. This last effect is associated with a time- and dose-dependent increase in levels of insoluble gastric mucin. Based on these known biological actions of TGF alpha, we have examined TGF alpha production in Ménétrier's disease, a disorder characterized by foveolar hyperplasia, hypochlorhydria, and increased gastric mucin content. In four patients with Ménétrier's disease, there was enhanced TGF alpha immunostaining throughout the gastric mucosa. Furthermore, metallothionein (MT)-TGF alpha transgenic mice which overproduce TGF alpha in the stomach exhibit histopathological and biochemical features characteristic of and consistent with the diagnosis of Ménétrier's disease. Thus locally produced TGF alpha may mediate a number of biological processes in the stomach, and its altered production may participate in the pathogenesis of selected pathological states.
1 Communities
1 Members
0 Resources
8 MeSH Terms
Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo.
Romano M, Polk WH, Awad JA, Arteaga CL, Nanney LB, Wargovich MJ, Kraus ER, Boland CR, Coffey RJ
(1992) J Clin Invest 90: 2409-21
MeSH Terms: Animals, Aspirin, Dinoprostone, Ethanol, Ethylmaleimide, Gastric Mucins, Gastric Mucosa, Image Processing, Computer-Assisted, Indomethacin, Microscopy, Electron, Scanning, Necrosis, Ornithine Decarboxylase, Phosphorylation, Phosphotyrosine, Rats, Rats, Sprague-Dawley, Sulfhydryl Compounds, Time Factors, Transforming Growth Factor alpha, Type C Phospholipases, Tyrosine
Show Abstract · Added March 5, 2014
This study was designed to determine whether transforming growth factor alpha (TGF alpha) protects rat gastric mucosa against ethanol- and aspirin-induced injury. Systemic administration of TGF alpha dose-dependently decreased 100% ethanol-induced gastric mucosal injury; a dose of 50 micrograms/kg delivered intraperitoneally 15 min before ethanol decreased macroscopic mucosal injury by > 90%. At the microscopic level, TGF alpha prevented deep gastric necrotic lesions and reduced disruption of surface epithelium. Pretreatment with orogastric TGF alpha (200 micrograms/kg) only partially (40%) decreased macroscopic ethanol damage. Intraperitoneal administration of TGF alpha at a dose of 10 micrograms/kg, which does not significantly inhibit gastric acid secretion, decreased aspirin-induced macroscopic damage by > 80%. TGF alpha protection does not seem to be mediated by prostaglandin, glutathione, or ornithine decarboxylase-related events, as evidenced by lack of influence of the inhibition of their production. Pretreatment with the sulfhydryl blocking agent N-ethylmaleimide partially abolished (40%) the protective effect of TGF alpha. In addition, systemic administration of TGF alpha resulted in a two-fold increase in tyrosine phosphorylation of phospholipase C-gamma 1 and in a time- and dose-dependent increase in levels of immunoreactive insoluble gastric mucin; these events occurred in a time frame consistent with their participation in the protective effect of TGF alpha.
1 Communities
2 Members
0 Resources
21 MeSH Terms